Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Arcadi Svirnovski, Vadim Pasiukov & Sergei Grigorovich. (2005) Vincristine resistance development in lymphoblastoid cells under conditions of selective P-glycoprotein inhibition. Hematology 10:4, pages 313-319.
Read now
Read now
Articles from other publishers (6)
Donghai Jiang, Meihua Sui, Wangyan Zhong, Yuan Huang & Weimin Fan. (2013) Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells. Cancer Letters 335:2, pages 404-411.
Crossref
Crossref
B. Zhang, S. Suer, F. Livak, S. Adediran, A. Vemula, M. A. Khan, Y. Ning & A. Hussain. (2012) Telomere and Microtubule Targeting in Treatment-Sensitive and Treatment-Resistant Human Prostate Cancer Cells. Molecular Pharmacology 82:2, pages 310-321.
Crossref
Crossref
Alexander V. LyubimovSteven J. Wolf & Caroline G. Lee. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
40
.
Robert Mallon, Larry R. Feldberg, Judy Lucas, Inder Chaudhary, Christoph Dehnhardt, Efren Delos Santos, Zecheng Chen, Osvaldo dos Santos, Semiramis Ayral-Kaloustian, Aranapakam Venkatesan & Irwin Hollander. (2011) Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor. Clinical Cancer Research 17:10, pages 3193-3203.
Crossref
Crossref
Xueshi Ye, Ting Liu, Yuping Gong, Bohui Zheng, Wentong Meng & Yamei Leng. (2009) Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Leukemia Research 33:8, pages 1114-1119.
Crossref
Crossref
Jing Jin, Hua Sun, Huailing Wei & Gengtao Liu. (2006) The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis. Investigational New Drugs 25:2, pages 95-105.
Crossref
Crossref